Neurotrack

Neurotrack is developing technology for screening of cognitive impairment. Almost 6 in 10 people with probable dementia are undiagnosed. To solve this problem, Neurotrack has developed digital cognitive assessments and cognitive health programs for clients or patients. Neurotrack’s technology distinguishes cognitive impairment from normal aging, outperforms the current “gold standard”, is culturally agnostic and is easy to track over time. With these advantages, Neurotrack’s patient-administered test enables screening with confidence in a fraction of the time.